Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 138
News
News | 16 March 2022

Jeffrey W. Fisher is the recipient of the Arnold J Lehman SOT award

Career achievement for contributions in Physiologically based pharmacokinetic (PBPK) and biologically based does response (BBDR) modelling tools

News
News | 16 March 2022

Bharat Biotech and Biofabri to develop and distribute novel TB vaccine

MTBVAC is a global public-private project that will be a milestone in the field of vaccinology

News
News | 16 March 2022

Boston Scientific opens second R&D centre in Pune

The centre will initially employ 170 engineers, bringing the total number of Boston Scientific’s R&D employees in India to more than 300

News
News | 15 March 2022

Biogen and Eisai amend collaboration agreements on Alzheimer’s disease treatments

Aducanumab collaboration to convert from Eisai sharing of global profits and losses to a global royalty arrangement, effective January 1, 2023

News
News | 15 March 2022

Granules Pharmaceuticals clears USFDA audit

This is the sixth successful USFDA audit for this facility

News
News | 15 March 2022

Live Pharma Coalition to organise its first-ever conclave in Mumbai

The focus is to build collaborative learning and sharing ecosystem

News
News | 15 March 2022

AbbVie and Scripps Research plan to develop anti-viral for Covid-19

The initial SARS-CoV-2 research program at Calibr, the drug discovery and development division of Scripps Research, was supported by funding from the Bill & Melinda Gates Foundation

News
News | 14 March 2022

USFDA clears Niramai's breast thermography device

The SMILE-100 System is a breast thermography device that helps healthcare personnel review, measure and analyze thermally significant indications in the breast region

News
News | 14 March 2022

Applications for PLI in bulk drugs extended till March 31st 2022

A total of 49 projects have been approved so far for 33 critical APIs with a committed investment of Rs 3,685 crore

News
News | 14 March 2022

Corbevax to be administered to children between 12-14 years

Govt announces vaccination programme for kids and those above 60 years of age

News
News | 14 March 2022

Dr Federica Fiorini is the winner of the 2022 Darlene Solomon award

The award recognizes and supports promising women scientists

News
News | 14 March 2022

Moderna dosed the first participant for an experimental HIV trimer mRNA vaccine

The open-label, multicenter, randomized Phase 1 trial is designed to evaluate the safety and immunogenicity of experimental HIV trimer mRNA vaccines

News
News | 13 March 2022

Japan tops CPhI ‘API Quality’ ranking for second year

Digital meetings driving international partnering at CPhI Japan as companies search for ingredients suppliers

News
News | 12 March 2022

Wipro and Pandorum partner to accelerate regenerative medicine with AI

Use of Wipro Holmes Artificial Intelligence capabilities will lead to faster development of advanced therapeutics, improving patient outcomes

News
News | 12 March 2022

Terran Biosciences acquires Concert’s CNS therapeutics portfolio

These new chemical entities are covered by composition of matter patent applications. Financial terms of the deal were not disclosed

News
News | 12 March 2022

Study shows Pfizer vaccine moderately effective against Omicron for children 5-15

The study looked at 1,364 children in Arizona, Florida, Texas, and Utah who submitted weekly nasal swabs and surveys from July 2021 through February 2022, regardless of whether they had symptoms

News
News | 11 March 2022

Aurobindo Pharma trains its managers to be `future ready’

Partners with GITAM University to train 27 employees through a 10-day HR module and make them future-ready

News
News | 10 March 2022

Medical devices production under PLI scheme gets off the ground

A total of 21 applicants have been approved for 49 products, with the potential to utilize an incentive amount of Rs. 2541 crore

News
News | 10 March 2022

Everlife acquires Research Instruments to boost presence in life science and clinical diagnostics

The RI investment comes on the back of three other recently completed transactions in Malaysia and Singapore in the last two months

News
News | 10 March 2022

Insilico Medicine and University of Zurich partner to find therapy for Cystinosis

The Mechanisms of Inherited Kidney Disorders (MIKADO) group at the University of Zurich (UZH) and Insilico Medicine will be working together to identify, rank, and annotate novel drug targets to identify potential therapeutics for cystinosis

Startup

Digitization